Imaging test for tumors using a new tracer agent
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a new imaging method (68Ga-DOTA-mPNE PET/CT) to see if it can help detect cancers. It's for people who haven't had chemotherapy or radiation yet and will have a biopsy or surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and expected to live at least 12 weeks.
- You cannot have had chemotherapy or radiation in the past.
- You must have at least one tumor that can be measured by standard imaging.
- You must be able to lie still for 30 minutes.
- Women who are pregnant, breastfeeding, or planning pregnancy cannot join. Others must use birth control during the study.
- You must agree to follow all study visits and provide written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a new radioactive tracer that attaches to a protein found on many solid tumors, allowing doctors to see tumors on a PET scan. It may help improve how tumors are detected and monitored.
This trial tests a new PET scan tracer to find neuroendocrine tumors in the body. It may help doctors see where the tumors are and plan better treatment.
This trial uses a special PET scan to see if a new imaging agent can find hard-to-treat pituitary tumors that have come back after surgery. It may help doctors decide the best way to manage these tumors.
This trial tests a new imaging method that uses a special dye to highlight a protein called Trop-2 found on some brain tumor cells. The goal is to see if this dye can help doctors see the tumor more clearly before surgery, which may improve surgical planning.
This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It is for people with certain types of cancer who are willing to have a biopsy of their tumor.
This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.
Hear when a new Malignant Neoplasms of Brain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.